<!DOCTYPE html>
<html>
<head>
<style>
table {
    font-family: arial, sans-serif;
    border-collapse: collapse;
    width: 100%;
}
td, th {
    border: 1px solid #dddddd;
    text-align: left;
    padding: 8px;
}
tr:nth-child(even) {
    background-color: #dddddd;
}
</style>
</head>
<body>

<table>
<tr>
<th>No.</th>
<th>Pathway</th>
<th>positive..r.</th>
<th>measured..n.</th>
<th>total</th>
<th>X.</th>
<th>Z.Score</th>
<th>p.value..permuted.</th>
<tr>



<tr>
<td>1</td>
<td> <a href="Hypothesized Pathways in Pathogenesis of Cardiovascular Disease/Hypothesized Pathways in Pathogenesis of Cardiovascular Disease.html">Hypothesized Pathways in Pathogenesis of Cardiovascular Disease</td>
<td>3</td>
<td>25</td>
<td>27</td>
<td>12.00%</td>
<td>4.5</td>
<td>0</td>
</tr>
<tr>
<td>2</td>
<td> <a href="Matrix Metalloproteinases/Matrix Metalloproteinases.html">Matrix Metalloproteinases</td>
<td>4</td>
<td>29</td>
<td>31</td>
<td>13.79%</td>
<td>5.67</td>
<td>0</td>
</tr>
<tr>
<td>3</td>
<td> <a href="PPAR signaling pathway/PPAR signaling pathway.html">PPAR signaling pathway</td>
<td>5</td>
<td>63</td>
<td>76</td>
<td>7.94%</td>
<td>4.42</td>
<td>0</td>
</tr>
<tr>
<td>4</td>
<td> <a href="Retinoblastoma (RB) in Cancer/Retinoblastoma (RB) in Cancer.html">Retinoblastoma (RB) in Cancer</td>
<td>7</td>
<td>86</td>
<td>98</td>
<td>8.14%</td>
<td>5.33</td>
<td>0</td>
</tr>
<tr>
<td>5</td>
<td> <a href="Amino Acid metabolism/Amino Acid metabolism.html">Amino Acid metabolism</td>
<td>5</td>
<td>85</td>
<td>205</td>
<td>5.88%</td>
<td>3.52</td>
<td>0.001</td>
</tr>
<tr>
<td>6</td>
<td> <a href="Fatty Acid Omega Oxidation/Fatty Acid Omega Oxidation.html">Fatty Acid Omega Oxidation</td>
<td>3</td>
<td>14</td>
<td>20</td>
<td>21.43%</td>
<td>6.36</td>
<td>0.001</td>
</tr>
<tr>
<td>7</td>
<td> <a href="Oxytocin signaling/Oxytocin signaling.html">Oxytocin signaling</td>
<td>1</td>
<td>4</td>
<td>10</td>
<td>25.00%</td>
<td>4.01</td>
<td>0.002</td>
</tr>
<tr>
<td>8</td>
<td> <a href="Ethanol effects on histone modifications/Ethanol effects on histone modifications.html">Ethanol effects on histone modifications</td>
<td>3</td>
<td>30</td>
<td>53</td>
<td>10.00%</td>
<td>4</td>
<td>0.003</td>
</tr>
<tr>
<td>9</td>
<td> <a href="Gastric Cancer Network 2/Gastric Cancer Network 2.html">Gastric Cancer Network 2</td>
<td>3</td>
<td>30</td>
<td>35</td>
<td>10.00%</td>
<td>4</td>
<td>0.003</td>
</tr>
<tr>
<td>10</td>
<td> <a href="Photodynamic therapy-induced NF-kB survival signaling/Photodynamic therapy-induced NF-kB survival signaling.html">Photodynamic therapy-induced NF-kB survival signaling</td>
<td>3</td>
<td>34</td>
<td>36</td>
<td>8.82%</td>
<td>3.68</td>
<td>0.003</td>
</tr>
<tr>
<td>11</td>
<td> <a href="Gastric Cancer Network 1/Gastric Cancer Network 1.html">Gastric Cancer Network 1</td>
<td>3</td>
<td>25</td>
<td>32</td>
<td>12.00%</td>
<td>4.5</td>
<td>0.006</td>
</tr>
<tr>
<td>12</td>
<td> <a href="TGF-beta Signaling Pathway/TGF-beta Signaling Pathway.html">TGF-beta Signaling Pathway</td>
<td>6</td>
<td>130</td>
<td>133</td>
<td>4.62%</td>
<td>3.13</td>
<td>0.007</td>
</tr>
<tr>
<td>13</td>
<td> <a href="Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)/Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs).html">Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)</td>
<td>1</td>
<td>5</td>
<td>14</td>
<td>20.00%</td>
<td>3.53</td>
<td>0.01</td>
</tr>
<tr>
<td>14</td>
<td> <a href="Lung fibrosis/Lung fibrosis.html">Lung fibrosis</td>
<td>4</td>
<td>61</td>
<td>85</td>
<td>6.56%</td>
<td>3.43</td>
<td>0.01</td>
</tr>
<tr>
<td>15</td>
<td> <a href="Irinotecan Pathway/Irinotecan Pathway.html">Irinotecan Pathway</td>
<td>1</td>
<td>10</td>
<td>18</td>
<td>10.00%</td>
<td>2.31</td>
<td>0.02</td>
</tr>
<tr>
<td>16</td>
<td> <a href="Folate-Alcohol and Cancer Pathway/Folate-Alcohol and Cancer Pathway.html">Folate-Alcohol and Cancer Pathway</td>
<td>1</td>
<td>7</td>
<td>23</td>
<td>14.29%</td>
<td>2.89</td>
<td>0.021</td>
</tr>
<tr>
<td>17</td>
<td> <a href="SRF and miRs in Smooth Muscle Differentiation and Proliferation/SRF and miRs in Smooth Muscle Differentiation and Proliferation.html">SRF and miRs in Smooth Muscle Differentiation and Proliferation</td>
<td>1</td>
<td>10</td>
<td>18</td>
<td>10.00%</td>
<td>2.31</td>
<td>0.021</td>
</tr>
<tr>
<td>18</td>
<td> <a href="Differentiation Pathway/Differentiation Pathway.html">Differentiation Pathway</td>
<td>3</td>
<td>48</td>
<td>64</td>
<td>6.25%</td>
<td>2.86</td>
<td>0.023</td>
</tr>
<tr>
<td>19</td>
<td> <a href="Vitamin A and Carotenoid Metabolism/Vitamin A and Carotenoid Metabolism.html">Vitamin A and Carotenoid Metabolism</td>
<td>2</td>
<td>41</td>
<td>65</td>
<td>4.88%</td>
<td>1.89</td>
<td>0.028</td>
</tr>
<tr>
<td>20</td>
<td> <a href="Endochondral Ossification/Endochondral Ossification.html">Endochondral Ossification</td>
<td>3</td>
<td>61</td>
<td>69</td>
<td>4.92%</td>
<td>2.34</td>
<td>0.029</td>
</tr>
<tr>
<td>21</td>
<td> <a href="Oxidative Stress/Oxidative Stress.html">Oxidative Stress</td>
<td>2</td>
<td>28</td>
<td>32</td>
<td>7.14%</td>
<td>2.58</td>
<td>0.029</td>
</tr>
<tr>
<td>22</td>
<td> <a href="NAD Biosynthesis II (from tryptophan)/NAD Biosynthesis II (from tryptophan).html">NAD Biosynthesis II (from tryptophan)</td>
<td>1</td>
<td>8</td>
<td>34</td>
<td>12.50%</td>
<td>2.66</td>
<td>0.03</td>
</tr>
<tr>
<td>23</td>
<td> <a href="Wntbeta-catenin Signaling Pathway in Leukemia/Wntbeta-catenin Signaling Pathway in Leukemia.html">Wntbeta-catenin Signaling Pathway in Leukemia</td>
<td>2</td>
<td>24</td>
<td>29</td>
<td>8.33%</td>
<td>2.88</td>
<td>0.03</td>
</tr>
<tr>
<td>24</td>
<td> <a href="Tryptophan metabolism/Tryptophan metabolism.html">Tryptophan metabolism</td>
<td>2</td>
<td>45</td>
<td>133</td>
<td>4.44%</td>
<td>1.73</td>
<td>0.039</td>
</tr>
<tr>
<td>25</td>
<td> <a href="Biogenic Amine Synthesis/Biogenic Amine Synthesis.html">Biogenic Amine Synthesis</td>
<td>1</td>
<td>15</td>
<td>33</td>
<td>6.67%</td>
<td>1.73</td>
<td>0.043</td>
</tr>
<tr>
<td>26</td>
<td> <a href="Spinal Cord Injury/Spinal Cord Injury.html">Spinal Cord Injury</td>
<td>4</td>
<td>112</td>
<td>127</td>
<td>3.57%</td>
<td>1.96</td>
<td>0.043</td>
</tr>
<tr>
<td>27</td>
<td> <a href="ACE Inhibitor Pathway/ACE Inhibitor Pathway.html">ACE Inhibitor Pathway</td>
<td>1</td>
<td>17</td>
<td>29</td>
<td>5.88%</td>
<td>1.57</td>
<td>0.046</td>
</tr>
<tr>
<td>28</td>
<td> <a href="Adipogenesis/Adipogenesis.html">Adipogenesis</td>
<td>4</td>
<td>128</td>
<td>132</td>
<td>3.13%</td>
<td>1.66</td>
<td>0.046</td>
</tr>
<tr>
<td>29</td>
<td> <a href="Development and heterogeneity of the ILC family/Development and heterogeneity of the ILC family.html">Development and heterogeneity of the ILC family</td>
<td>2</td>
<td>32</td>
<td>33</td>
<td>6.25%</td>
<td>2.33</td>
<td>0.048</td>
</tr>
<tr>
<td>30</td>
<td> <a href="4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression/4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression.html">4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression</td>
<td>1</td>
<td>18</td>
<td>31</td>
<td>5.56%</td>
<td>1.5</td>
<td>0.049</td>
</tr>




</table>

</body>
</html>